Arrivent Biopharma Inc. (AVBP)
Market Open
20 Jul, 18:11
NASDAQ (NMS) NASDAQ (NMS) Primary $
30. 56
-2.63
-7.9241%
$
1.52B Market Cap
- P/E Ratio
- Div Yield
537,954 Volume
- Eps
$ 33.19
Previous Close 
Want to track AVBP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Arrivent Biopharma Inc. (AVBP) Statistics
Valuation metrics
Market Cap 1.52B
Enterprise value 1.48B
Trailing P/E (ttm) -9.4
Forward P/E -
PEG ratio -9.18
Price/Sales (ttm) -
Price/Book (mrq) 4.62
Enterprise Value/Revenue -
Enterprise Value/EBITDA -10.22
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 834.04K
Average volume (90 days) 481.29K
Price summary
52-Week low 16.1
52-Week high 35.83
Beta -
50-Day moving average 31.55
200-Day moving average 25.29
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.42%
Return on equity -0.49%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.22
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.24
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 13.95%
Book value per share (mrq) 7.19
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
